🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations

RecruitingNAAges 18 Years - anyAllCiusss de L'Est de l'Île de Montréal
NCT07902518 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn whether theta-burst transcranial magnetic stimulation (TBS), a non-invasive brain stimulation technique, can help reduce persistent auditory verbal hallucinations (hearing voices) in adults with psychotic disorders who have not responded adequately to antipsychotic medications. The main questions it aims to answer are: * Does theta-burst stimulation reduce the severity of auditory verbal hallucinations? * Does theta-burst stimulation improve other psychiatric symptoms, including depressive symptoms and insight into illness? * How well do participants tolerate this treatment, and what side effects do they experience? All participants will receive active theta-burst stimulation. There is no placebo or comparison group. Participants will: * Complete an initial assessment of their mental health, symptoms, and medical history. * Receive 20 brai

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older. * Diagnosis of a schizophrenia-spectrum disorder or bipolar disorder with psychotic symptoms. * Presence of persistent auditory verbal hallucinations with persecutory content. * Auditory verbal hallucinations s that have not responded to ≥2 antipsychotic trials, each lasting more than 6 weeks, with daily chlorpromazine-equivalent doses of ≥600 mg and ≥80% of doses taken. * Stable pharmacological treatment for at least two months before enrollment. Exclusion Criteria: * History of epilepsy or seizures. * Neurological disorders that may interfere with the study or increase the risks associated with transcranial magnetic stimulation. * Substance use disorder within the previous six months. * Electroconvulsive therapy (ECT) within the previous six months. * Any other contraindication to transcranial magnetic stimulation.
💊

What it tests

  • Theta-Burst Transcranial Magnetic Stimulation (TBS)
📍

Where

1 site
Institut universitaire en santé mentale de Montréal
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy